Biovica
Business Services · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Dag Hammarskjölds Väg Science Uppsala Pa...Phone Number
+46 184444830Website
www.biovica.comRevenue
<$5 MillionStock Symbol
BIOVIC-BIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Biovica
Founded in 2009 and headquartered in Uppsala, Sweden, Biovica is a cancer-focused biotech company that partners with leading cancer institutes, collaborative groups, and pharmaceutical companies to provide product development in the area of innovative biomarker-based testing.Explore more
Biovica Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biovica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Biovica
Check if Biovica has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Biovica launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Biovica is spiking on competitors!
Earning: See what the market has to say on Biovica recently announced quarterly report
Funding: Get notified immidiatlly once Biovica has new funding data
Click to see if Biovica had a recent Job posting/layoffs
Biovica, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Biovica is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Biovica is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Biovica.
Biovica Tech Stack
A closer look at the technologies used by Biovica
Most Recent Scoops
Project
Biovica has built a clinical evidence base for DiviTum TKa comprising more than 30 publications covering more than 5,000 patients across multiple study programs, demonstrating the ability to provide clinical insight up to 83 days before imaging in hormone receptor-positive metastatic breast cancer.
Clinical Operations
Earnings
Biovica has reported Q4 sales of SEK 4.8 million, the strongest quarter to date, driven by US IVD testing and pharma service revenues, with full-year sales of SEK 13.4 million, representing approximately 55% growth in SEK and 74% growth in local currency year-over-year. The cash position at the end of the reporting period was SEK 70.4 million, with Q4 operating cash flow improving to SEK -16 million compared to SEK -17.8 million in the prior year period.
Earnings, Accounting, Financial Reporting, Business Finance, Finance
Project
withdrew its financial targets last autumn, citing delays in US clinical studies and slower-than-expected pipeline maturation. The company has not yet issued new guidance, as the incoming CEO remains in a listening mode while evaluating several opportunities, some of which are described as binary in nature.
Clinical Operations, Finance, Risk
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company, Board of Directors
Biovica News & Media
Biovica establishes DiviTum(R) TKa Commercialization Partnership in Italy
Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, today announces that the company has signed a commercial partnership agreement with the Italian company, IT Health Fusion, for the commercialization of the DiviTum® TKa assay in Italy.Q1 Interim Report May-July 2022/2023 - DiviTum(R)TKa Approved for Launch in the US
Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)Biovica Receives FDA Approval for DiviTum(R)TKa
Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II).
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biovica
Sign Up For FreeTo access detailed company insights
Founded in 2009 and headquartered in Uppsala, Sweden, Biovica is a cancer-focused biotech company that partners with leading cancer institutes, collaborative groups, and pharmaceutical companies to provide product development in the area of innovative biomarker-based testing.... Read More
